Letter to the Editor: Can the Ratio of Serum HBV RNA to DNA Reflect the Reverse‐Transcription Efficiency of Viral pgRNA?

HepatologyVolume 74, Issue 1 p. 532-533 Correspondence Letter to the Editor: Can the Ratio of Serum HBV RNA to DNA Reflect the Reverse-Transcription Efficiency of Viral pgRNA? Wanying Li, Wanying Li State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaSearch for more papers by this authorRui Deng, Rui Deng State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaSearch for more papers by this authorShi Liu, Shi Liu State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaSearch for more papers by this authorHaitao Guo, Haitao Guo orcid.org/0000-0002-7146-916X Cancer Virology Program, UPMC Hillman Cancer Center, Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PASearch for more papers by this authorJian Sun, Jian Sun orcid.org/0000-0001-5320-227X State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaSearch for more papers by this author Wanying Li, Wanying Li State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaSearch for more papers by this authorRui Deng, Rui Deng State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaSearch for more papers by this authorShi Liu, Shi Liu State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaSearch for more papers by this authorHaitao Guo, Haitao Guo orcid.org/0000-0002-7146-916X Cancer Virology Program, UPMC Hillman Cancer Center, Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PASearch for more papers by this authorJian Sun, Jian Sun orcid.org/0000-0001-5320-227X State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaSearch for more papers by this author First published: 23 December 2020 https://doi.org/10.1002/hep.31691 Supported by the National Science and Technology Major Project (2017ZX10202202), Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (2017BT01S131), and the National Natural Science Foundation of China (8207034797). Potential conflict of interest: Dr. Guo consults for Assembly and owns stock in Arbutus. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume74, Issue1July 2021Pages 532-533 RelatedInformation